1092563-25-1 Usage
General Description
4-[4-(4,4,5,5-tetramethyl[1,3,2]dioxaborolan-2-yl)benzyl]thiomorpholine 1,1-dioxide is a complex chemical compound that is used in various industrial and research applications. It is a thiomorpholine derivative containing a dioxaborolane moiety, which gives it unique properties and reactivity. This chemical has been used in the development of pharmaceuticals, agrochemicals, and materials science. It is also used as a reagent in organic synthesis and as a building block for more complex molecules. Additionally, this compound has potential applications in the field of catalysis and as a ligand in metal-complex chemistry. Additionally, it is important to handle this chemical with caution, as it may pose health and environmental risks if not properly managed.
Check Digit Verification of cas no
The CAS Registry Mumber 1092563-25-1 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,0,9,2,5,6 and 3 respectively; the second part has 2 digits, 2 and 5 respectively.
Calculate Digit Verification of CAS Registry Number 1092563-25:
(9*1)+(8*0)+(7*9)+(6*2)+(5*5)+(4*6)+(3*3)+(2*2)+(1*5)=151
151 % 10 = 1
So 1092563-25-1 is a valid CAS Registry Number.
1092563-25-1Relevant articles and documents
PROCESSES FOR THE PREPARATION OF FILGOTINIB
-
Paragraph 0092-0093, (2020/03/09)
The present invention relates to processes for the preparation of Filgotinib. The present invention relates to novel processes for the preparation of filgotinib. The present invention also relates to novel intermediates for the preparation of filgotinib.
PYRROLO-AROMATIC HETEROCYCLIC COMPOUND, PREPARATION METHOD THEREFOR, AND MEDICAL USE THEREOF
-
Paragraph 0221; 0222, (2019/11/11)
The present invention relates to pyrrolo-aromatic heterocyclic compounds, a preparation method therefor and medical use thereof. Particularly, the present invention relates to a compound represented by formula I, a preparation method therefor, a pharmaceu
[1,2,4]triazol[1,5-a]pyridine compound as well as preparation method and medical application thereof
-
Paragraph 0220-0221, (2018/03/24)
The invention relates to a [1,2,4]triazol[1,5-a] pyridine compound as well as a preparation method and medical application thereof. Particularly, the invention relates to the compound shown in a general formula I, the preparation method of the compound, a